Know Cancer

or
forgot password
  • cancer clinical trials in hershey, PA

  • Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Head and Neck Cancer
    Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma
    Penn State Hershey Medical Center
    Hershey, Pennsylvania 17033
    Melanoma, Neoplasm Metastasis
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    Penn State Hershey Medical Center
    Hershey, Pennsylvania 17033
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
    Hershey Medical Center
    Hershey, Pennsylvania 17033
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Lung Cancer
    Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Pancreatic Cancer
    Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Lymphoma
    Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Lymphoma
    Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Sarcoma
    Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Cervical Cancer
    Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Lung Cancer
    Endometrial Biopsy in Infertile Patients
    Pennsylvania State University
    Hershey, Pennsylvania 17033
    Infertility
    Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Metastatic Cancer, Sarcoma
    Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor
    Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions
    Penn State Milton S Hershey Medical Center
    Hershey, Pennsylvania 17033
    Anemia, Sickle Cell
    Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma With Sarcomatoid Features
    Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Vulvar Cancer
    Treatment of Infertility in Women With Polycystic Ovary Syndrome
    Penn State
    Hershey, Pennsylvania 17033
    Polycystic Ovary Syndrome, Infertility, Pregnancy
    Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Leukemia
    Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Lymphoma
    Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Endometrial Cancer
    Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Sarcoma
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    Penn State Hershey Children's Hospital
    Hershey, Pennsylvania 17033
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Anal Cancer, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ, Radiation Enteritis
    Bortezomib in Treating Patients With Newly Diagnosed High-Risk Stage III Multiple Myeloma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Multiple Myeloma, Plasma Cell Neoplasm
    Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Brain and Central Nervous System Tumors
    hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Neuroblastoma
    Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Brain Tumor, Central Nervous System Tumor
    Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Endometrial Cancer
    Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Levocarnitine in Treating Fatigue in Cancer Patients
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
    Penn State Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033
    Melanoma, Metastases
    Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Brain and Central Nervous System Tumors
    Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Sarcoma
    Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Mesothelioma
    Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Lung Cancer
    Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Brain and Central Nervous System Tumors
    Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Pancreatic Cancer
    Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Leukemia
    Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors
    Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Lung Cancer
    Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Sarcoma
    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Breast Cancer
    Ultrasound and Endometrial Hyperplasia
    Penn State Milton S. Hershey
    Hershey, Pennsylvania 17033
    Endometrial Hyperplasia
    The Effects of Continuous Administration of a Monophasic Oral Contraceptive on Bleeding Days and Endometrial and Ovarian Function
    The Penn State Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Menstrual Cycle, Healthy
    Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS)
    Penn State Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033
    Polycystic Ovary Syndrome
    Pharmacokinetics and Safety of Transdermal Megestrol Acetate
    Hershey Medical Center
    Hershey, Pennsylvania 17033
    Cachexia
    Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Lymphoma
    Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload
    Hershey Medical Center
    Hershey, Pennsylvania 17033
    Thalassemia, Sickle Cell Disease, Diamond Blackfan Anemia, Myelofibrosis
    Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
    Milton S Hershey Medical Center
    Hershey, Pennsylvania 17033
    Cancer, Breakthrough Pain
    Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain
    Milton S Hershey Medical Center
    Hershey, Pennsylvania 17033
    Pain, Cancer, Sickle Cell Anemia, Severe Burns
    Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Breast Cancer
    Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    Penn State Milton S Hershey Medical Center
    Hershey, Pennsylvania 17033
    Recurrent Adult Acute Lymphoblastic Leukemia
    Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
    Penn State Hershey Children's Hospital
    Hershey, Pennsylvania 17033
    Stage I Lymphoepithelioma of the Nasopharynx, Stage I Squamous Cell Carcinoma of the Nasopharynx, Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Brain and Central Nervous System Tumors
    Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Neuroblastoma
    Response to Tipifarnib in Individuals With Large Granular Lymphocyte Leukemia
    Pennsylvania State University
    Hershey, Pennsylvania 17033
    Leukemia, Lymphocytic, Neutropenia, Anemia
    Effect of High-Legume Diet on Colorectal Cancer Risk
    Pennsylvania State University
    Hershey, Pennsylvania 17033
    Adenomas, Colorectal Adenoma, Colon Adenomas
    The Second Multicenter Hemophilia Cohort Study
    Milton Hershey Medical Center
    Hershey, Pennsylvania 17033-2390
    Liver Decompensation, Hepatocellular Carcinoma, Non-Hodgkin Lymphoma
    A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash
    Penn State Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033
    Rash, Non-small-Cell Lung Cancer
    High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma
    Penn State Cancer Institute at Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033-0850
    Sarcoma
    A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer
    Penn State Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033
    Hepatocellular Carcinoma (HCC)
    Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease
    Penn State Hershey Medical Center
    Hershey, Pennsylvania 17033
    Graft Versus Host Disease
    Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer
    Penn State Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033
    Non-small Cell Lung Cancer
    A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)
    Penn State Hershey Medical Center
    Hershey, Pennsylvania 17033
    Acute Myelogenous Leukemia, Acute Myeloid Leukemia
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    Penn State Hershey Children's Hospital
    Hershey, Pennsylvania 17033
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
    Penn State Hershey Children's Hospital
    Hershey, Pennsylvania 17033
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Graft Versus Host Disease, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia
    Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients
    Penn State Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033
    Cytomegalovirus Infections